Dublin-based Covidien announced on its Web site that it has signed a merger agreement with Somanetics Corp. (Troy, MI). Under the agreement, Covidien will acquire all outstanding shares of Somanetics for a total of $250 million, net of cash acquired.

June 17, 2010

1 Min Read
Covidien to Acquire Somanetics Corp.

Somanetics makes cerebal and somatic oximetry products, including the In-Vivo Optical Spectroscopy. Covidien says that the acquisition of the manufacturer will enable it to "add another market-leading technology to its portfolio."

The transaction is expected to be completed by July 31, 2010.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like